<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p238" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_238{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_238{left:306px;bottom:30px;}
#t3_238{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_238{left:346px;bottom:30px;}
#t5_238{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_238{left:517px;bottom:30px;}
#t7_238{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_238{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_238{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_238{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_238{left:35px;bottom:777px;letter-spacing:0.17px;word-spacing:0.02px;}
#tc_238{left:35px;bottom:759px;letter-spacing:0.11px;word-spacing:0.08px;}
#td_238{left:35px;bottom:739px;letter-spacing:0.02px;word-spacing:0.17px;}
#te_238{left:35px;bottom:720px;letter-spacing:0.03px;word-spacing:0.16px;}
#tf_238{left:35px;bottom:700px;letter-spacing:0.16px;}
#tg_238{left:405px;bottom:700px;}
#th_238{left:35px;bottom:665px;letter-spacing:0.04px;word-spacing:0.15px;}
#ti_238{left:35px;bottom:645px;letter-spacing:0.04px;word-spacing:0.15px;}
#tj_238{left:35px;bottom:625px;letter-spacing:0.02px;word-spacing:0.16px;}
#tk_238{left:35px;bottom:606px;letter-spacing:0.16px;}
#tl_238{left:405px;bottom:606px;}
#tm_238{left:35px;bottom:570px;letter-spacing:0.12px;word-spacing:0.06px;}
#tn_238{left:35px;bottom:551px;letter-spacing:0.15px;word-spacing:0.04px;}
#to_238{left:35px;bottom:531px;letter-spacing:0.03px;word-spacing:0.16px;}
#tp_238{left:35px;bottom:512px;letter-spacing:0.09px;word-spacing:-0.58px;}
#tq_238{left:35px;bottom:492px;letter-spacing:0.07px;word-spacing:0.11px;}
#tr_238{left:35px;bottom:473px;letter-spacing:0.16px;}
#ts_238{left:405px;bottom:473px;}
#tt_238{left:35px;bottom:437px;letter-spacing:0.07px;word-spacing:0.12px;}
#tu_238{left:35px;bottom:418px;letter-spacing:0.02px;word-spacing:0.17px;}
#tv_238{left:35px;bottom:398px;letter-spacing:0.11px;word-spacing:0.08px;}
#tw_238{left:35px;bottom:379px;letter-spacing:0.16px;}
#tx_238{left:405px;bottom:379px;}
#ty_238{left:35px;bottom:343px;letter-spacing:0.08px;word-spacing:0.11px;}
#tz_238{left:35px;bottom:324px;letter-spacing:-0.01px;word-spacing:0.19px;}
#t10_238{left:35px;bottom:304px;letter-spacing:0.07px;word-spacing:0.12px;}
#t11_238{left:35px;bottom:284px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t12_238{left:132px;bottom:284px;letter-spacing:0.16px;}
#t13_238{left:501px;bottom:284px;}
#t14_238{left:35px;bottom:249px;letter-spacing:0.1px;word-spacing:0.09px;}
#t15_238{left:35px;bottom:229px;letter-spacing:0.05px;word-spacing:0.14px;}
#t16_238{left:35px;bottom:210px;letter-spacing:0.05px;word-spacing:0.14px;}
#t17_238{left:35px;bottom:190px;letter-spacing:0.09px;word-spacing:0.1px;}
#t18_238{left:35px;bottom:171px;letter-spacing:0.16px;}
#t19_238{left:405px;bottom:171px;}
#t1a_238{left:35px;bottom:135px;letter-spacing:0.13px;word-spacing:0.06px;}
#t1b_238{left:35px;bottom:116px;letter-spacing:0.03px;word-spacing:0.15px;}
#t1c_238{left:35px;bottom:96px;letter-spacing:-0.01px;word-spacing:0.2px;}
#t1d_238{left:35px;bottom:78px;letter-spacing:0.07px;word-spacing:0.11px;}
#t1e_238{left:35px;bottom:58px;letter-spacing:0.16px;}
#t1f_238{left:405px;bottom:58px;}
#t1g_238{left:618px;bottom:777px;letter-spacing:0.13px;word-spacing:-0.83px;}
#t1h_238{left:618px;bottom:759px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1i_238{left:618px;bottom:739px;letter-spacing:-0.05px;word-spacing:0.24px;}
#t1j_238{left:618px;bottom:720px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1k_238{left:618px;bottom:700px;letter-spacing:0.16px;}
#t1l_238{left:988px;bottom:700px;}
#t1m_238{left:618px;bottom:665px;letter-spacing:-0.01px;word-spacing:0.2px;}
#t1n_238{left:618px;bottom:645px;letter-spacing:0.18px;word-spacing:0.01px;}
#t1o_238{left:618px;bottom:625px;word-spacing:0.19px;}
#t1p_238{left:618px;bottom:606px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1q_238{left:618px;bottom:586px;letter-spacing:0.16px;}
#t1r_238{left:988px;bottom:586px;}
#t1s_238{left:618px;bottom:551px;letter-spacing:0.09px;word-spacing:0.09px;}
#t1t_238{left:618px;bottom:531px;letter-spacing:0.02px;word-spacing:0.17px;}
#t1u_238{left:618px;bottom:512px;letter-spacing:0.01px;word-spacing:0.18px;}
#t1v_238{left:618px;bottom:492px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1w_238{left:618px;bottom:473px;letter-spacing:0.16px;}
#t1x_238{left:988px;bottom:473px;}
#t1y_238{left:618px;bottom:437px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1z_238{left:618px;bottom:418px;letter-spacing:0.09px;word-spacing:0.1px;}
#t20_238{left:618px;bottom:398px;word-spacing:-0.8px;}
#t21_238{left:618px;bottom:379px;letter-spacing:0.1px;word-spacing:0.09px;}
#t22_238{left:618px;bottom:359px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t23_238{left:715px;bottom:359px;letter-spacing:0.16px;}
#t24_238{left:1084px;bottom:359px;}
#t25_238{left:618px;bottom:324px;letter-spacing:0.08px;word-spacing:0.11px;}
#t26_238{left:618px;bottom:304px;letter-spacing:0.13px;word-spacing:0.06px;}
#t27_238{left:618px;bottom:284px;letter-spacing:0.06px;word-spacing:0.12px;}
#t28_238{left:618px;bottom:266px;letter-spacing:0.04px;word-spacing:0.15px;}
#t29_238{left:618px;bottom:247px;letter-spacing:0.16px;}
#t2a_238{left:988px;bottom:247px;}
#t2b_238{left:618px;bottom:210px;letter-spacing:0.04px;word-spacing:0.15px;}
#t2c_238{left:618px;bottom:190px;letter-spacing:-0.02px;word-spacing:-1.02px;}
#t2d_238{left:618px;bottom:172px;letter-spacing:0.04px;word-spacing:0.32px;}
#t2e_238{left:618px;bottom:152px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t2f_238{left:715px;bottom:152px;letter-spacing:0.16px;}
#t2g_238{left:1084px;bottom:152px;}
#t2h_238{left:618px;bottom:116px;letter-spacing:0.08px;word-spacing:0.1px;}
#t2i_238{left:618px;bottom:96px;letter-spacing:0.14px;word-spacing:0.05px;}
#t2j_238{left:618px;bottom:78px;letter-spacing:0.02px;word-spacing:-0.36px;}
#t2k_238{left:618px;bottom:58px;letter-spacing:0.05px;word-spacing:0.13px;}
#t2l_238{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_238{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_238{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_238{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_238{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_238{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_238{font-size:17px;font-family:ArialMT_5tg;color:#005B99;}
.s6_238{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts238" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg238Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg238" style="-webkit-user-select: none;"><object width="1210" height="935" data="238/238.svg" type="image/svg+xml" id="pdf238" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_238" class="t s0_238">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_238" class="t s1_238">© </span>
<span id="t3_238" class="t s0_238">(NCCN </span>
<span id="t4_238" class="t s1_238">© </span>
<span id="t5_238" class="t s0_238">), All rights reserved. NCCN Guidelines </span>
<span id="t6_238" class="t s1_238">® </span>
<span id="t7_238" class="t s0_238">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_238" class="t s2_238">NCCN Guidelines Version 4.2024 </span>
<span id="t9_238" class="t s2_238">Head and Neck Cancers </span>
<span id="ta_238" class="t s3_238">MS-97 </span>
<span id="tb_238" class="t s4_238">509. Tang LL, Guo R, Zhang N, et al. Effect of radiotherapy alone vs </span>
<span id="tc_238" class="t s4_238">radiotherapy with concurrent chemoradiotherapy on survival without </span>
<span id="td_238" class="t s4_238">disease relapse in patients with low-risk nasopharyngeal carcinoma: a </span>
<span id="te_238" class="t s4_238">randomized clinical trial. JAMA 2022;328:728-736. Available at: </span>
<span id="tf_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/35997729</span><span id="tg_238" class="t s4_238">. </span>
<span id="th_238" class="t s4_238">510. Blanchard P, Lee A, Marguet S, et al. Chemotherapy and </span>
<span id="ti_238" class="t s4_238">radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC </span>
<span id="tj_238" class="t s4_238">meta-analysis. Lancet Oncol 2015;16:645-655. Available at: </span>
<span id="tk_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/25957714</span><span id="tl_238" class="t s4_238">. </span>
<span id="tm_238" class="t s4_238">511. Yang Q, Cao SM, Guo L, et al. Induction chemotherapy followed by </span>
<span id="tn_238" class="t s4_238">concurrent chemoradiotherapy versus concurrent chemoradiotherapy </span>
<span id="to_238" class="t s4_238">alone in locoregionally advanced nasopharyngeal carcinoma: long-term </span>
<span id="tp_238" class="t s4_238">results of a phase III multicentre randomised controlled trial. Eur J Cancer </span>
<span id="tq_238" class="t s4_238">2019;119:87-96. Available at: </span>
<span id="tr_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/31425966</span><span id="ts_238" class="t s4_238">. </span>
<span id="tt_238" class="t s4_238">512. Zhang Y, Chen L, Hu GQ, et al. Gemcitabine and cisplatin induction </span>
<span id="tu_238" class="t s4_238">chemotherapy in nasopharyngeal carcinoma. N Engl J Med </span>
<span id="tv_238" class="t s4_238">2019;381:1124-1135. Available at: </span>
<span id="tw_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/31150573</span><span id="tx_238" class="t s4_238">. </span>
<span id="ty_238" class="t s4_238">513. Ribassin-Majed L, Marguet S, Lee AWM, et al. What is the best </span>
<span id="tz_238" class="t s4_238">treatment of locally advanced nasopharyngeal carcinoma? An individual </span>
<span id="t10_238" class="t s4_238">patient data network meta-analysis. J Clin Oncol 2017;35:498-505. </span>
<span id="t11_238" class="t s4_238">Available at: </span><span id="t12_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/27918720</span><span id="t13_238" class="t s4_238">. </span>
<span id="t14_238" class="t s4_238">514. Chen YP, Tang LL, Yang Q, et al. Induction chemotherapy plus </span>
<span id="t15_238" class="t s4_238">concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: </span>
<span id="t16_238" class="t s4_238">individual patient data pooled analysis of four randomized trials. Clin </span>
<span id="t17_238" class="t s4_238">Cancer Res 2018;24:1824-1833. Available at: </span>
<span id="t18_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/29431618</span><span id="t19_238" class="t s4_238">. </span>
<span id="t1a_238" class="t s4_238">515. Tan TH, Soon YY, Cheo T, et al. Induction chemotherapy for locally </span>
<span id="t1b_238" class="t s4_238">advanced nasopharyngeal carcinoma treated with concurrent </span>
<span id="t1c_238" class="t s4_238">chemoradiation: A systematic review and meta-analysis. Radiother Oncol </span>
<span id="t1d_238" class="t s4_238">2018;129:10-17. Available at: </span>
<span id="t1e_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/29555182</span><span id="t1f_238" class="t s4_238">. </span>
<span id="t1g_238" class="t s4_238">516. Wang P, Zhang M, Ke C, Cai C. The efficacy and toxicity of induction </span>
<span id="t1h_238" class="t s4_238">chemotherapy plus concurrent chemoradiotherapy in locoregionally </span>
<span id="t1i_238" class="t s4_238">advanced nasopharyngeal carcinoma: a meta-analysis of randomized </span>
<span id="t1j_238" class="t s4_238">controlled trials. Medicine (Baltimore) 2020;99:e19360. Available at: </span>
<span id="t1k_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/32150078</span><span id="t1l_238" class="t s4_238">. </span>
<span id="t1m_238" class="t s4_238">517. Chen YP, Ismaila N, Chua MLK, et al. Chemotherapy in combination </span>
<span id="t1n_238" class="t s4_238">with radiotherapy for definitive-intent treatment of stage II-IVA </span>
<span id="t1o_238" class="t s4_238">nasopharyngeal carcinoma: CSCO and ASCO Guideline. J Clin Oncol </span>
<span id="t1p_238" class="t s4_238">2021;39:840-859. Available at: </span>
<span id="t1q_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/33405943</span><span id="t1r_238" class="t s4_238">. </span>
<span id="t1s_238" class="t s4_238">518. Petit C, Lee A, Ma J, et al. Role of chemotherapy in patients with </span>
<span id="t1t_238" class="t s4_238">nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an </span>
<span id="t1u_238" class="t s4_238">updated individual patient data network meta-analysis. Lancet Oncol </span>
<span id="t1v_238" class="t s4_238">2023;24:611-623. Available at: </span>
<span id="t1w_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/37269842</span><span id="t1x_238" class="t s4_238">. </span>
<span id="t1y_238" class="t s4_238">519. You R, Cao YS, Huang PY, et al. The changing therapeutic role of </span>
<span id="t1z_238" class="t s4_238">chemo-radiotherapy for loco-regionally advanced nasopharyngeal </span>
<span id="t20_238" class="t s4_238">carcinoma from two/three-dimensional radiotherapy to intensity-modulated </span>
<span id="t21_238" class="t s4_238">radiotherapy: a network meta-analysis. Theranostics 2017;7:4825-4835. </span>
<span id="t22_238" class="t s4_238">Available at: </span><span id="t23_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/29187906</span><span id="t24_238" class="t s4_238">. </span>
<span id="t25_238" class="t s4_238">520. Lee AWM, Ngan RKC, Ng WT, et al. NPC-0501 trial on the value of </span>
<span id="t26_238" class="t s4_238">changing chemoradiotherapy sequence, replacing 5-fluorouracil with </span>
<span id="t27_238" class="t s4_238">capecitabine, and altering fractionation for patients with advanced </span>
<span id="t28_238" class="t s4_238">nasopharyngeal carcinoma. Cancer 2020;126:3674-3688. Available at: </span>
<span id="t29_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/32497261</span><span id="t2a_238" class="t s4_238">. </span>
<span id="t2b_238" class="t s4_238">521. Miao J, Wang L, Tan SH, et al. Adjuvant capecitabine following </span>
<span id="t2c_238" class="t s4_238">concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal </span>
<span id="t2d_238" class="t s4_238">carcinoma: a randomized clinical trial. JAMA Oncol 2022;8:1776-1785. </span>
<span id="t2e_238" class="t s4_238">Available at: </span><span id="t2f_238" class="t s5_238">https://www.ncbi.nlm.nih.gov/pubmed/36227615</span><span id="t2g_238" class="t s4_238">. </span>
<span id="t2h_238" class="t s4_238">522. Liu GY, Li WZ, Wang DS, et al. Effect of capecitabine maintenance </span>
<span id="t2i_238" class="t s4_238">therapy plus best supportive care vs best supportive care alone on </span>
<span id="t2j_238" class="t s4_238">progression-free survival among patients with newly diagnosed metastatic </span>
<span id="t2k_238" class="t s4_238">nasopharyngeal carcinoma who had received induction chemotherapy: a </span>
<span id="t2l_238" class="t s6_238">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
